Atika Capital Management LLC Exact Sciences Corp Transaction History

Atika Capital Management LLC

$841 Million
Q2 2024

A detailed history of Atika Capital Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Atika Capital Management LLC holds 211,120 shares of EXAS stock, worth $13.9 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

211,120

Previous 1,600 13095.0%

Holding current value

$13.9 Million

Previous $110,000 8008.18%

% of portfolio

1.06%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$41.33 - $74.26 $160,360 - $288,128	-3,880 Reduced 1.8%	211,120 $8.92 Million
Q1 2024 May 14, 2024	BUY	$56.27 - $73.77 $5.23 Million - $6.86 Million	93,000 Added 76.23%	215,000 $14.8 Million
Q4 2023 Feb 13, 2024	BUY	$59.06 - $75.72 $4.61 Million - $5.91 Million	78,000 Added 177.27%	122,000 $9.03 Million
Q3 2023 Nov 13, 2023	SELL	$65.94 - $99.04 $13.1 Million - $19.7 Million	-199,000 Reduced 81.89%	44,000 $3 Million
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $15.2 Million - $23.1 Million	243,000 New	243,000 $22.8 Million
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $5.08 Million - $7.05 Million	-70,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$116.57 - $155.01 $3.77 Million - $5.01 Million	-32,300 Reduced 31.57%	70,000 $9.23 Million
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $886,529 - $1.26 Million	-8,900 Reduced 8.0%	102,300 $13.6 Million
Q3 2020 Nov 13, 2020	BUY	$72.92 - $102.01 $3.44 Million - $4.81 Million	47,200 Added 73.75%	111,200 $11.3 Million
Q2 2020 Aug 13, 2020	SELL	$55.75 - $92.75 $947,750 - $1.58 Million	-17,000 Reduced 20.99%	64,000 $5.56 Million
Q1 2020 May 14, 2020	BUY	$37.9 - $104.44 $322,150 - $887,740	8,500 Added 11.72%	81,000 $4.7 Million
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $2.14 Million - $2.74 Million	-27,500 Reduced 27.5%	72,500 $6.71 Million
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $3.19 Million - $4.32 Million	-35,300 Reduced 26.09%	100,000 $9.04 Million
Q2 2019 Aug 12, 2019	SELL	$89.51 - $118.04 $2.03 Million - $2.68 Million	-22,700 Reduced 14.37%	135,300 $16 Million
Q1 2019 May 13, 2019	BUY	$61.98 - $96.5 $464,850 - $723,750	7,500 Added 4.98%	158,000 $13.7 Million
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $1.43 Million - $2.11 Million	25,500 Added 20.4%	150,500 $9.5 Million
Q3 2018 Nov 14, 2018	BUY	$48.29 - $80.6 $338,030 - $564,200	7,000 Added 5.93%	125,000 $9.87 Million
Q2 2018 Aug 14, 2018	BUY	$37.84 - $69.96 $3.65 Million - $6.75 Million	96,500 Added 448.84%	118,000 $7.06 Million
Q1 2018 May 15, 2018	SELL	$39.82 - $57.53 $1.65 Million - $2.39 Million	-41,500 Reduced 65.87%	21,500 $867,000
Q4 2017 Feb 14, 2018	SELL	$46.49 - $60.51 $1.26 Million - $1.63 Million	-27,000 Reduced 30.0%	63,000 $3.31 Million
Q3 2017 Nov 14, 2017	SELL	$37.05 - $47.12 $35,049 - $44,575	-946 Reduced 1.04%	90,000 $4.24 Million
Q2 2017 Aug 14, 2017	BUY	N/A	90,946	90,946 $3.22 Million

Others Institutions Holding EXAS

# of Institutions

610

Shares Held

166M

Call Options Held

1.93M

Put Options Held

1.23M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.7B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.

Account

Atika Capital Management LLC Exact Sciences Corp Transaction History